Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 05 January 2026 Vol. No. 15 ; Issue No.716
Publications

1. Moirangthem R, Patil A, Chitkara G, Kar S, Smith GD, Dikshit R, Mhatre S (2025). Association between digit ratio (2D:4D) and right-left difference in 2D:4D ratio with breast cancer risk: multicentre case-control study from India. Scientific Reports.

2. Pradhan P, Chaudhary T, Mishra S, Konik P, Durinova E, Tuma R, De A, Sinha D (2026). MCJ modulates mitochondrial ETC flux to promote lipid metabolism-driven enhancement of cell proliferation and migration. Cell Death and Disease.

3. Janu AK, Rai P, Choudhari AJ, Gala K, Puri A, Pruthi M, Ramadwar M, Panjwani P, Nayak P, Pathak P, Chakrabarty N, Parambil BC, Khanna N, Laskar S, Shetty N, Kulkarni S (2026). Comparison of FRACTURE MRI, conventional radiography, and CT in the evaluation of bone tumors. radiology: Imaging Cancer. 8(1):e240525.

Book Chapter
Amulraj P, Kumar J, CM Krishna, Noothalpati H, Panneerselvam R (2025). Raman spectroscopy: A potential tool for cancer analysis. In: Muniraj I, Hennelly B (Eds.) Spectroscopic Techniques for Cancer Diagnostics. IOP Publishing Ltd. Pp. 6-36. (ISBN: 978-0-7503-5947-4)

Thesis
Supriya Amol Hait. 2025. An Integrative Approch to Understand Resistance to Tyrosine Kinase Inhibitors in Human Lung Cancer. (LIFE09201704013) (Guide: Dr. Syed K Hasan)

Site of the Week

Shorthand DB' provides stable identifiers for lipids described at lower levels of resolution than the full-structure level contained within LMSD.

desktop Image
Interesting Reads

Montagna G, Alvarado M, Myers S, Mrdutt MM, Sun SX, Sevilimedu V, Barrio AV, van den Bruele AB, Boughey JC, Boyle MK, Crown A, Kesmodel SB, King TA, Kuerer HM, Leisha EC, Moo TA, Weiss A, Williams AD, Parmar P, Diskin B, Hlavin C, Diego EJ, Polidorio N, Abdelwahab K, Banys-Paluchowski M, Kurzeder C, Heidinger M, Goldschmidt M, Schulz A, Heil J, Karadeniz Cakmak G, Pislar N, Riis M, Prakash I, Ovalle V, Ugurlu MU, Franceschini G, Sergeevich EA, Morales J, Lee HB, Galimberti V, Ahn SG, Ryu JM, Muslumanoglu M, Cabıoğlu N, Yoo TR, Vrancken Peeters MJ, Ferrucci M, Morrow M, Weber WP; microNAC Study Group (2026). Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study. Lancet Oncol. 27(1):57-67.

Video of the Week
Mapping CAR T Cell Therapy: Strategies to Maximize Expansion, Persistence, Trafficking & Efficacy
Upcoming Events
Workshop on Fundamentals of Cervical Cancer Screening, Colposcopy & Pre-cancer Management

January 15-16, 2026

At ACTREC, Tata Memorial Centre, Kharghar

XXIV ANNUAL CONFERENCE Evidence Based Management of Cancers in India 2026

February 27-01 March 2026

At Tata Memorial Hospital, Prof. R. D. Choksi Auditorium, Parel, Mumbai

National Cancer Grid (NCG) Advanced Tracheostomy Course: Multidisciplinary Inter professional Approach

February 21-22, 2026

At Prof RD Choksi Auditorium, Tata Memorial Hospital, Mumbai

Do You Know?

In 2012, Smart-seq, a method to generate high-coverage transcriptomes from single cells, was used to analyse the full-length messenger-RNA transcriptomes of circulating tumour cells from a patient with melanoma

back Image
Cancer News
Inheritable genetic variant offers protection against blood cancer risk and progression.

Eurekalert, 01/12/2026

A newly identified and rare genetic variant slows the growth of mutated blood stem cells, researchers report, and it reduces the risk of leukemia. The findings offer insight into why some people are naturally more resistant to clonal expansion and age-...

Scientists discover hidden link between two hallmarks of cancer.

SciTechDaily, 31/12/2025

Scientists have uncovered a shared molecular process that connects two defining features of cancer. These include the ability of cancer cells to avoid apoptosis (a form of programmed cell death) and their tendency to rewire how they generate and use energy...

Breast cancer drug boosts leukemia treatment: Unexpected duo shows promise in overcoming resistance.

MedicalXpress,29/12/2025

In a study, researchers analyzed more than 300 acute myeloid leukemia, or AML, patient samples and found that pairing venetoclax, a standard AML drug, with palbociclib, a cell-cycle inhibitor currently approved for breast cancer, produced significantly stronger and more durable anti-leukemia...

2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)